Literature DB >> 25957113

Microarchitectural and mechanical characterization of the sickle bone.

Mykel Green1, Idowu Akinsami2, Angela Lin3, Shereka Banton2, Samit Ghosh4, Binbin Chen2, Manu Platt2, Ifeyinwa Osunkwo5, Solomon Ofori-Acquah4, Robert Guldberg3, Gilda Barabino6.   

Abstract

Individuals with sickle cell disease often experience acute and chronic bone pain due to occlusive events within the tissue vasculature that result in ischemia, necrosis, and organ degeneration. Macroscopically, sickle bone is identified in clinical radiographs by its reduced mineral density, widening of the marrow cavity, and thinning of the cortical bone due to the elevated erythroid hyperplasia accompanying the disease. However, the microstructural architecture of sickle bone and its role in mechanical functionality is largely unknown. This study utilized micro-CT and biomechanical testing to determine the relationship between the bone morphology, tissue mineral density, and trabecular and cortical microarchitecture of 10- and 21-week-old femurs from transgenic sickle male mice and littermates with sickle trait, as well as a wild-type control. While bone tissue mineral density did not vary among the genotypes at either age, variation in bone microstructure were observed. At 10 weeks, healthy and trait mice exhibited similar morphology within the cortical and trabecular bone, while sickle mice exhibited highly connected trabeculae. Within older femurs, sickle and trait specimens displayed significantly fewer trabeculae, and the remaining trabeculae had a more deteriorated geometry based on the structure model index. Thinning of the cortical region in sickle femurs contributed to the displayed flexibility with a significantly lower elastic modulus than the controls at both 10- and 21-weeks old. Wild-type and trait femurs generally demonstrated similar mechanical properties; however, trait femurs had a significantly higher modulus than sickle and wild-type control at 21-weeks. Overall, these data indicate that the progressive damage to the microvasculature caused by sickle cell disease, results in deleterious structural changes in the bone tissue׳s microarchitecture and mechanics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomechanics; Bone; Micro-CT; Microarchitecture; Sickle cell disease

Mesh:

Year:  2015        PMID: 25957113      PMCID: PMC4442736          DOI: 10.1016/j.jmbbm.2015.04.019

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  54 in total

Review 1.  Dual-energy radiographic absorptiometry for bone densitometry: current status and perspective.

Authors:  D J Sartoris; D Resnick
Journal:  AJR Am J Roentgenol       Date:  1989-02       Impact factor: 3.959

2.  Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.

Authors:  N Bonnet; C L Benhamou; B Brunet-Imbault; A Arlettaz; M N Horcajada; O Richard; L Vico; K Collomp; D Courteix
Journal:  Bone       Date:  2005-09-12       Impact factor: 4.398

3.  Knockout-transgenic mouse model of sickle cell disease.

Authors:  T M Ryan; D J Ciavatta; T M Townes
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

4.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia.

Authors:  M R Brinker; K A Thomas; S J Meyers; T Texada; J R Humbert; S D Cook; R Gitter
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1998-01

6.  Sickle cell disease as a cause of osteonecrosis of the femoral head.

Authors:  P F Milner; A P Kraus; J I Sebes; L A Sleeper; K A Dukes; S H Embury; R Bellevue; M Koshy; J W Moohr; J Smith
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

7.  Pathological fracture complicating long bone osteomyelitis in patients with sickle cell disease.

Authors:  W W Ebong
Journal:  J Pediatr Orthop       Date:  1986 Mar-Apr       Impact factor: 2.324

Review 8.  Musculoskeletal manifestations of sickle cell disease.

Authors:  Vivian C Ejindu; Andrew L Hine; Mohammad Mashayekhi; Philip J Shorvon; Rakesh R Misra
Journal:  Radiographics       Date:  2007 Jul-Aug       Impact factor: 5.333

Review 9.  Sickle red cell-endothelium interactions.

Authors:  Dhananjay K Kaul; Eileen Finnegan; Gilda A Barabino
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

10.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  7 in total

1.  Multiscale investigation on the effects of additional weight bearing in combination with low-magnitude high-frequency vibration on bone quality of growing female rats.

Authors:  Tianlong Zhang; Jiazi Gao; Juan Fang; He Gong
Journal:  J Bone Miner Metab       Date:  2017-03-14       Impact factor: 2.626

2.  Sickle cell bone disease and response to intravenous bisphosphonates in children.

Authors:  C Grimbly; P Diaz Escagedo; J L Jaremko; A Bruce; N Alos; M E Robinson; V N Konji; M Page; M Scharke; E Simpson; Y D Pastore; R Girgis; R T Alexander; L M Ward
Journal:  Osteoporos Int       Date:  2022-07-29       Impact factor: 5.071

Review 3.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

Review 4.  Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.

Authors:  Viktória Jeney
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

5.  Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice.

Authors:  Jada Selma; Hannah Song; Christian Rivera; Simone Douglas; Abhiramgopal Akella; Keval Bollavaram; Nishone Thompson; Manu O Platt; Edward A Botchwey
Journal:  Blood Adv       Date:  2022-03-08

Review 6.  Influence of Iron on Bone Homeostasis.

Authors:  Enikő Balogh; György Paragh; Viktória Jeney
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18

7.  Spatiotemporal Alterations in Gait in Humanized Transgenic Sickle Mice.

Authors:  Stacy Kiven; Ying Wang; Anupam Aich; Donovan A Argueta; Jianxun Lei; Varun Sagi; Madhushan Tennakoon; Saad J Bedros; Nils Lambrecht; Kalpna Gupta
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.